Sitagliptin Prophylaxis for Glucocorticoid-Induced Impairment of Glucose Metabolism and Beta-Cell Dysfunction in Males With the Metabolic Syndrome X: A Randomized, Placebo-Controlled, Double-Blind Intervention Study With a 2x2 Factorial Design.
Phase of Trial: Phase II
Latest Information Update: 25 Apr 2014
At a glance
- Drugs Sitagliptin (Primary) ; Prednisolone
- Indications Metabolic syndrome
- Focus Therapeutic Use
- Acronyms SPHINX
- 29 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Jun 2012 Actual patient number is 82 according to ClinicalTrials.gov.
- 29 Jun 2012 Actual end date (Jun 2012) added as reported by ClinicalTrials.gov.